Role of the CYP1A2 gene polymorphism on early ageing from occupational exposur

Balkan Journal of Medical Genetics

Volumn 16, Issue 2, 2013, Pages 45-52

  Eshkoor, S A ^a   Ismail, P ^a   Rahman, S A ^a   Moin, S ^a   Adon, M Y ^b  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b INSTITUTE FOR MEDICAL RESEARCH   (Malaysia)

Author keywords

Ageing; Buccal Cells; Cytochrome P450 (CYP), Cytochrome P450 1A2 (CYP1A2) gene polymorphism; Micronuclei (MN) test; Occupational exposure

Indexed keywords

CYTOCHROME P450 1A2; TOXIC SUBSTANCE;

ADULT; AGING; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA DAMAGE; DNA POLYMORPHISM; GENOTOXICITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MICRONUCLEUS; OCCUPATIONAL EXPOSURE; REAL TIME POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; WORKSHOP;

EID: 84903591989     PISSN: None     EISSN: 13110160     Source Type: Journal    
DOI: 10.2478/bjmg-2013-0031     Document Type: Article

References (24)

1. Vijg J. Somatic mutations and aging: a re-evaluation. Mutat Res. 2000; 447(1): 117-135. (Pubitemid 30109315)
2. Wojda A, Witt M. Manifestations of aging at the cytogenetic level. J Appl Genet. 2003; 44(3): 383-399.
3. Harman D. The aging process: major risk factor for disease and death. Proc Nat Acad Sci USA. 1991; 88(12): 5360-5363. (Pubitemid 21914744)
4. Pande M, Amos CI, Osterwisch DR, Chen J, Lynch PM, Broaddus R, et al. Genetic variation in genes for the xenobiotic-metabolizing enzymes CYP1A1, EPHX1, GSTM1, GSTT1, and GSTP1 and susceptibility to colo-rectal cancer in Lynch Syndrome. Cancer Epidemiol Bio-markers Prev. 2008; 17(9): 2393-2399.
5. Lautraite S, Musonda AC, Doehmer J, Edwards GO, Chipman JK. Flavonoids inhibit genetic tox-icity produced by carcinogens in cells expressing CYP1A2 and CYP1A1. Mutagenesis. 2002; 17(1): 45-53. (Pubitemid 34083385)
6. Al Zabadi H, Ferrari L, Laurent AM, Tiberguent A, Paris C, Zmirou-Navier D. Biomonitoring of complex occupational exposures to carcinogens: the case of sewage workers in Paris. BMC Cancer. 2008; 8(1): 67-77.
7. Vainio H. Use of biomarkers in risk assessment. Int J Hyg Environ Health. 2001; 204(2-3): 91-102. (Pubitemid 33078044)
8. Martino-Roth MG, Viegas J, Amaral M, Oliveira L, Ferreira FLS, Erdtmann B. Evaluation of geno-toxicity through micronuclei test in workers of car and battery repair garages. Genet Mol Biol. 2002; 25(4): 495-500. (Pubitemid 36305014)
9. Eshkoor SA, Ismail P, Rahman SA, Moin S. Does GSTP1 polymorphism contribute to genetic damage caused by ageing and occupational exposure? Arh Hig Rada Toksikol. 2011; 62(4): 291-298.
10. Cawthon RM. Telomere measurement by quantitative PCR. Nucleic Acids Res. 2002; 30(10): e47.
11. Nakajima M, Yokoi T, Mizutani M, Kinoshita M, Funayama M, Kamataki T. Genetic polymorphism in the 5'-fanking region of human CY-P1A2 gene: effect on the CYP1A2 inducibility in humans. J Biochem. 1999; 125(4): 803-808. (Pubitemid 29192503)
12. Pavanello S, Pulliero A, Lupi S, Gregorio P, Clon-fero E. Infuence of the genetic polymorphism in the 5'-noncoding region of the CYP1A2 gene on CYP1A2 phenotype and urinary mutagenicity in smokers. Mutat Res. 2005; 587(1-2): 59-66. (Pubitemid 41503581)
13. Hashizumea T, Yoshitomia S, Asahia S, Matsu-muraa S, Chatania F, Odab H. In vitro micro-nucleus test in HepG2 transformants expressing a series of human cyto-chrome P450 isoforms with chemicals requiring metabolic activation. Mutat Res. 2009; 677(1-2): 1-7.
14. da Silva J, Moraes CR, Heuser VD, Andrade VM, Silva FR, Kvitko K, et al. Evaluation of genetic damage in a Brazilian population occupation-ally exposed to pesticides and its correlation with polymorphisms in metabolizing genes. Mutagen-esis. 2008; 23(5): 415-422.
15. Castorena-Torres F, Mendoza-Cantu A, de Leon MB, Cisneros B, Zapata-Perez O, López-Carrillo L, et al. CYP1A2 phenotype and genotype in a population from the carboniferous region of Coa-huila, Mexico. Toxicol Lett. 2005; 156(3): 331-339. (Pubitemid 40342566)
16. Bageman E, Ingvar C, Rose C, Jernstrom H. Coffee consumption and CYP1A2*1F genotype modify age at breast cancer diagnosis and estrogen receptor status. Cancer Epidemiol Biomarkers Prev. 2008; 17(4): 895-901. (Pubitemid 351536421)
17. Iba MM, Fung J. Pulmonary CYP1A1 and CY-P1A2 levels and activities in adult male and female offspring of rats exposed during gestation and lactation to 2, 3, 7, 8-tetrachlorodibenzo-p-di-oxin. Biochem Pharmacol. 2001; 62(5): 617-626. (Pubitemid 32738773)
18. Sata F, Yamada H, Suzuki K, Saijo Y, Kato EH, Morikawa M, et al. Caffeine intake, CYP1A2 polymorphism and the risk of recurrent pregnancy loss. Mol Hum Reprod. 2005; 11(5): 357-360. (Pubitemid 41417869)
19. Kirsch-Volders M, Mateuca RA, Roelants M, Tremp A, Zeiger E, Bonassi S, et al. The effects of GSTM1 and GSTT1 polymorphisms on mi-cronucleus frequencies in human lymphocytes in vivo. Cancer Epi-demiol Biomarkers Prev. 2006; 15(5): 1038-1042. (Pubitemid 43823537)
20. Garte S, Taioli E, Popov T, Kalina I, Sram R, Farmer P. Role of GSTT1 deletion in DNA oxida-tive damage by exposure to polycyclic aromatic hydrocarbons in humans. Int J Cancer. 2006; 120(11): 2499-2503. (Pubitemid 46642140)
21. Palma S, Cornetta T, Padua L, Cozzi R, Appol-loni M, Ievoli E, et al. Infuence of glutathione S-transferase polymorphisms on genotoxic effects induced by tobacco smoke. Mutat Res. 2007; 633(1): 1-12. (Pubitemid 47096812)
22. Zhan P, Wang J, Zhang Y, Qiu LX, Zhao SF, Qian Q, et al. CYP2E1 Rsa I/Pst I polymorphism is associated with lung cancer risk among Asians. Lung Cancer. 2010; 69(1): 19-25.
23. Pinto D, Ceballos JM, Garcia G, Guzman P, Del Razo LM, Vera E, et al. Increased cytogenetic damage in outdoor painters. Mutat Res. 2000; 467(2): 105-111. (Pubitemid 30323621)
24. Manikantan P, Balachandar V, Sasikala K. DNA Damage in workers occupationally exposed to lead, using comet assay. Int J Biol. 2010; 2(1): 103-110.